230 related articles for article (PubMed ID: 10477295)
41. Targeted overexpression of osteoactivin in cells of osteoclastic lineage promotes osteoclastic resorption and bone loss in mice.
Sheng MH; Wergedal JE; Mohan S; Amoui M; Baylink DJ; Lau KH
PLoS One; 2012; 7(4):e35280. PubMed ID: 22536365
[TBL] [Abstract][Full Text] [Related]
42. Follicle-stimulating hormone increases bone mass in female mice.
Allan CM; Kalak R; Dunstan CR; McTavish KJ; Zhou H; Handelsman DJ; Seibel MJ
Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22629-34. PubMed ID: 21149714
[TBL] [Abstract][Full Text] [Related]
43. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
[TBL] [Abstract][Full Text] [Related]
44. Critical roles of the TGF-beta type I receptor ALK5 in perichondrial formation and function, cartilage integrity, and osteoblast differentiation during growth plate development.
Matsunobu T; Torigoe K; Ishikawa M; de Vega S; Kulkarni AB; Iwamoto Y; Yamada Y
Dev Biol; 2009 Aug; 332(2):325-38. PubMed ID: 19501582
[TBL] [Abstract][Full Text] [Related]
45. Elevated Gα11 expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate.
Dela Cruz A; Grynpas MD; Mitchell J
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E811-20. PubMed ID: 27006198
[TBL] [Abstract][Full Text] [Related]
46. Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation.
Zhao G; Monier-Faugere MC; Langub MC; Geng Z; Nakayama T; Pike JW; Chernausek SD; Rosen CJ; Donahue LR; Malluche HH; Fagin JA; Clemens TL
Endocrinology; 2000 Jul; 141(7):2674-82. PubMed ID: 10875273
[TBL] [Abstract][Full Text] [Related]
47. PTH battles TGF-beta in bone.
Atfi A; Baron R
Nat Cell Biol; 2010 Mar; 12(3):205-7. PubMed ID: 20190828
[TBL] [Abstract][Full Text] [Related]
48. Transgenic mice overexpressing insulin-like growth factor binding protein-5 display transiently decreased osteoblastic function and osteopenia.
Devlin RD; Du Z; Buccilli V; Jorgetti V; Canalis E
Endocrinology; 2002 Oct; 143(10):3955-62. PubMed ID: 12239107
[TBL] [Abstract][Full Text] [Related]
49. Constitutive activity of the osteoblast Ca2+-sensing receptor promotes loss of cancellous bone.
Dvorak MM; Chen TH; Orwoll B; Garvey C; Chang W; Bikle DD; Shoback DM
Endocrinology; 2007 Jul; 148(7):3156-63. PubMed ID: 17412806
[TBL] [Abstract][Full Text] [Related]
50. Overexpression of Gα
Zhang L; Sugamori KS; Claridge C; Dela Cruz A; Grynpas MD; Mitchell J
J Bone Miner Res; 2017 Nov; 32(11):2171-2181. PubMed ID: 28727179
[TBL] [Abstract][Full Text] [Related]
51. FIAT represses ATF4-mediated transcription to regulate bone mass in transgenic mice.
Yu VW; Ambartsoumian G; Verlinden L; Moir JM; Prud'homme J; Gauthier C; Roughley PJ; St-Arnaud R
J Cell Biol; 2005 May; 169(4):591-601. PubMed ID: 15911876
[TBL] [Abstract][Full Text] [Related]
52. Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.
Kassem M; Kveiborg M; Eriksen EF
Eur J Clin Invest; 2000 May; 30(5):429-37. PubMed ID: 10809903
[TBL] [Abstract][Full Text] [Related]
53. Disruption of BMP signaling in osteoblasts through type IA receptor (BMPRIA) increases bone mass.
Kamiya N; Ye L; Kobayashi T; Lucas DJ; Mochida Y; Yamauchi M; Kronenberg HM; Feng JQ; Mishina Y
J Bone Miner Res; 2008 Dec; 23(12):2007-17. PubMed ID: 18684091
[TBL] [Abstract][Full Text] [Related]
54. GPCR kinase 2 interacting protein 1 (GIT1) regulates osteoclast function and bone mass.
Menon P; Yin G; Smolock EM; Zuscik MJ; Yan C; Berk BC
J Cell Physiol; 2010 Nov; 225(3):777-85. PubMed ID: 20568227
[TBL] [Abstract][Full Text] [Related]
55. Conditional disruption of calcineurin B1 in osteoblasts increases bone formation and reduces bone resorption.
Yeo H; Beck LH; Thompson SR; Farach-Carson MC; McDonald JM; Clemens TL; Zayzafoon M
J Biol Chem; 2007 Nov; 282(48):35318-27. PubMed ID: 17884821
[TBL] [Abstract][Full Text] [Related]
56. Piezoelectric Microvibration Mitigates Estrogen Loss-Induced Osteoporosis and Promotes Piezo1, MicroRNA-29a, and Wnt3a Signaling in Osteoblasts.
Wu RW; Lian WS; Chen YS; Ko JY; Wang SY; Jahr H; Wang FS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502380
[TBL] [Abstract][Full Text] [Related]
57. Increased Bone Turnover and Possible Accelerated Fracture Healing in a Murine Model With an Increased Circulating C-Type Natriuretic Peptide.
Kondo E; Yasoda A; Fujii T; Nakao K; Yamashita Y; Ueda-Sakane Y; Kanamoto N; Miura M; Arai H; Mukoyama M; Inagaki N; Nakao K
Endocrinology; 2015 Jul; 156(7):2518-29. PubMed ID: 25860030
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of TGF-β signaling by 1D11 antibody treatment increases bone mass and quality in vivo.
Edwards JR; Nyman JS; Lwin ST; Moore MM; Esparza J; O'Quinn EC; Hart AJ; Biswas S; Patil CA; Lonning S; Mahadevan-Jansen A; Mundy GR
J Bone Miner Res; 2010 Nov; 25(11):2419-26. PubMed ID: 20499365
[TBL] [Abstract][Full Text] [Related]
59. Semaphorin 3B is a 1,25-Dihydroxyvitamin D3-induced gene in osteoblasts that promotes osteoclastogenesis and induces osteopenia in mice.
Sutton AL; Zhang X; Dowd DR; Kharode YP; Komm BS; Macdonald PN
Mol Endocrinol; 2008 Jun; 22(6):1370-81. PubMed ID: 18356290
[TBL] [Abstract][Full Text] [Related]
60. Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis.
Lin SJ; Ho HC; Lee YF; Liu NC; Liu S; Li G; Shyr CR; Chang C
Reprod Biol Endocrinol; 2012 Jun; 10():43. PubMed ID: 22676849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
